Dr. Marie Hudson, MD MPH
Claim this profileJewish General Hospital - CIUSSS-COMTL
Affiliated Hospitals
Jewish General Hospital - CIUSSS-COMTL
Sir Mortimer B. Davis Jewish General Hospital
Clinical Trials Marie Hudson, MD MPH is currently running
Mycophenolate Mofetil
for Systemic Sclerosis with Interstitial Lung Disease
The goal of this pilot study is to assess the feasibility of a larger study on the efficacy of mycophenolate mofetil in people diagnosed with systemic sclerosis with mild lung involvement. Participants will be recruited over 12 months at 3 academic centers and assigned randomly to receive either mycophenolate mofetil or placebo, a look-alike substance that contains no active drug, for 96 weeks.
Recruiting
0 awards
Phase 2
7 criteria
Immune Checkpoint Inhibitors
for Cancer
Immune checkpoint inhibitors (ICI) are among the most promising approaches to fighting cancer. However, a substantial percentage of patients experience off-target adverse effects in the form of mild to severe inflammation in different organs, commonly called immune-related adverse events (irAEs). irAEs can lead to treatment discontinuation, or can be life-threatening in extreme cases. The causes of irAEs are largely unknown and there are no reliable predictive biomarkers. The Montreal Immune-Related Adverse Events (MIRAE) study collects clinical information and biospecimens (blood, tissue, stool) from cancer patients treated with ICI to facilitate research on the identification of predictive biomarkers of irAEs, their causes, and the design of effective management strategies.
Recruiting
1 award
N/A
4 criteria
More about Marie Hudson, MD MPH
Clinical Trial Related
1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Marie Hudson, MD MPH has experience with
- Placebo
- Anti-IL6
- JAKi
- TNFi
- UCMSC
- Mycophenolate Mofetil
Breakdown of trials Marie Hudson, MD MPH has run
Systemic Sclerosis
Rheumatoid Arthritis
Mesenchymal Stem Cells
Interstitial Lung Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marie Hudson, MD MPH specialize in?
Marie Hudson, MD MPH focuses on Systemic Sclerosis and Rheumatoid Arthritis. In particular, much of their work with Systemic Sclerosis has involved treating patients, or patients who are undergoing treatment.
Is Marie Hudson, MD MPH currently recruiting for clinical trials?
Yes, Marie Hudson, MD MPH is currently recruiting for 4 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Marie Hudson, MD MPH has studied deeply?
Yes, Marie Hudson, MD MPH has studied treatments such as Placebo, Anti-IL6, JAKi.
What is the best way to schedule an appointment with Marie Hudson, MD MPH?
Apply for one of the trials that Marie Hudson, MD MPH is conducting.
What is the office address of Marie Hudson, MD MPH?
The office of Marie Hudson, MD MPH is located at: Jewish General Hospital - CIUSSS-COMTL, Montreal, Quebec H3T 1E2 Canada. This is the address for their practice at the Jewish General Hospital - CIUSSS-COMTL.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.